Valproate encephalopathy and hypocarnitinaemia in diabetic patients
- PMID: 7799006
- DOI: 10.1007/BF00873521
Valproate encephalopathy and hypocarnitinaemia in diabetic patients
Abstract
Two patients with epilepsy and diabetes mellitus developed encephalopathy while on valproate monotherapy. Low plasma carnitine levels were found. Discontinuation of valproate was followed by clinical recovery and normalization of carnitine levels. Both valproate treatment and diabetes mellitus may contribute to secondary carnitine deficiency, with resultant encephalopathy. Thus, diabetic patients may be at increased risk of developing valproate encephalopathy associated with hypocarnitinaemia.
Similar articles
-
Reversible weakness and encephalopathy while on long-term valproate treatment due to carnitine deficiency.BMJ Case Rep. 2015 Sep 2;2015:bcr2015210727. doi: 10.1136/bcr-2015-210727. BMJ Case Rep. 2015. PMID: 26336183 Free PMC article.
-
[A case report of valproate encephalopathy].Rinsho Shinkeigaku. 1999 Oct;39(10):1075-7. Rinsho Shinkeigaku. 1999. PMID: 10655774 Japanese.
-
Carnitine Deficiency in Chinese Children with Epilepsy on Valproate Monotherapy.Indian Pediatr. 2018 Mar 15;55(3):222-224. Indian Pediatr. 2018. PMID: 29629695
-
[The decreased level of plasma carnitine in patients with epilepsy].Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(6):106-110. doi: 10.17116/jnevro201711761106-110. Zh Nevrol Psikhiatr Im S S Korsakova. 2017. PMID: 28745680 Review. Russian.
-
[Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting].Vertex. 2008 Nov-Dec;19(82):371-7. Vertex. 2008. PMID: 19424520 Review. Spanish.
Cited by
-
Acquired encephalopathy associated with carnitine deficiency after cefditoren pivoxil administration.Neurol Sci. 2012 Dec;33(6):1393-6. doi: 10.1007/s10072-012-0939-7. Epub 2012 Jan 19. Neurol Sci. 2012. PMID: 22258360
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical